Johnson & Johnson Traded Down 0.25% on 53rd-Highest Volume Amid Regulatory Scrutiny and Supply Chain Shifts

Generado por agente de IAAinvest Volume Radar
viernes, 12 de septiembre de 2025, 7:55 pm ET1 min de lectura

. 12, 2025, , ranking 53rd in market activity for the day. The stock's performance followed mixed signals from its healthcare division amid ongoing regulatory scrutiny over its diabetes drug portfolio and recent supply chain adjustments in its consumer health business.

. Meanwhile, , . However, . .

, . , . , , , . Once finalized, . , , to present, .

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios